Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,668,106 papers from all fields of science
Search
Sign In
Create Free Account
Macaque simian foamy virus
Known as:
Simian foamy virus (TYPE 1)
, Simian foamy virus 1
, Simian foamy virus type 1
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Spumavirus
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Derivation and Functional Characterization of a Consensus DNA Binding Sequence for the Tas Transcriptional Activator of Simian Foamy Virus Type 1
Yibin Kang
,
B. Cullen
Journal of Virology
1998
Corpus ID: 25430204
ABSTRACT Although DNA binding sites specific for the Bel-1 and Tas transcriptional activators, encoded, respectively, by the…
Expand
Highly Cited
1996
Highly Cited
1996
Cell tropism of the simian foamy virus type 1 (SFV‐1)
A. Mergia
,
N. J. Leung
,
Jeanne Blackwell
Journal of medical primatology
1996
Corpus ID: 35148544
Abstract: Several cell lines representing different species and cell types were tested for simian foamy virus type 1 (SFV‐1…
Expand
1985
1985
Purification and characterization of the major envelope glycoprotein of simian foamy virus type 1.
A. B. Benzair
,
A. Rhodes-Feuillette
,
J. Lasneret
,
R. Emanoil-Ravier
,
J. Périès
Journal of General Virology
1985
Corpus ID: 30362494
Simian foamy virus type 1 (SFV-1), the prototype of the Spumavirinae, was subjected to disruption and serial purification…
Expand
1977
1977
A haemagglutination assay for the primate syncytium-forming (foamy) viruses.
J. Périès
,
G. Todaro
Journal of General Virology
1977
Corpus ID: 19278902
Preparations of highly concentrated simian foamy virus type 1 (SFV1)agglutinate guinea pig red blood cells. The agglutination…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE